Clinical surveillance testing after lung cancer operations

Naunheim, Keith S.; Virgo, Katherine S.; Coplin, Margaret A.; Johnson, Frank E.

doi:10.1016/0003-4975(95)00762-8

Cited by 39 publications

(19 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Follow-up programs after curative resection of NSCLC range from occasional chest radiography to intensive and systematic testing [17]. Some retrospective analyses of intensive follow-up programs [18][19][20] have demonstrated no advantages in survival or quality of life over a symptombased approach or a less-intensive regimen.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of intensive follow-up after response in patients with small cell lung cancer

et al. 2008

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Effectiveness of intensive follow-up after response in patients with small cell lung cancer

et al. 2008

View full text Add to dashboard Cite

“…The primary deviation from NCCN oncology guidelines for surveillance of definitively resected stage I and stage II NSCLC patients is in performing excessive radiographic testing [5]. The typical approach goes beyond the quarterly chest x-ray and physical examination by the thoracic surgeon (or other qualified practitioner) as recommended by NCCN and frequently includes a CT scan, complete blood count, and blood chemistries [6]. Magnetic resonance imaging (MRI) of the brain, positron emission tomography (PET) scans, and other serologic testing methods are included in many regimens.…”

Section: Opinion Statementmentioning

confidence: 99%

“…The reasons for this are varied and may include the influence of instructors during residency and fellowship, perceived medico-legal risk, and patient desire that something be done to follow the cancer [6]. In addition, some have argued that in addition to detecting recurrences and complications of surgery, follow-up visits are important for the doctor-patient relationship and are of educational value to the surgeon…”

Section: Introductionmentioning

confidence: 95%

Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection

Edelman

Schuetz

2002

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

Non-small-cell lung cancer (NSCLC) is responsible for more deaths each year in the United States than is any other malignancy. Early stage disease can be cured with surgical resection. Postoperative surveillance for recurrent disease and the development of second malignancies are important parts of the overall treatment plan. Follow-up strategies have been analyzed and guidelines (most notably those of the National Comprehensive Cancer Network ) have been published. However, common practice often does not comply with these rationally developed guidelines. Understanding the general principles of effective surveillance may improve compliance with the guidelines and may lead to more cost-effective management. New methods of surveillance, postoperative risk stratification, and emerging therapies may alter these recommendations for postoperative surveillance of patients with early stage NSCLC in the future.

show abstract

“…Although several guidelines have been published [1][2][3][4], follow-up regimens differ among nations, institutions, or even among attending surgeons within a single healthcare facility [5][6][7][8][9]. The survey of the Society of Thoracic Surgeons showed a marked variation in follow-up regimens after complete resection of lung cancer [10,11]. Some researchers believe an earlier diagnosis of cancer recurrence may lead to a better chance of therapeutic success [12].…”

Section: Introductionmentioning

confidence: 99%